MINK

Welcome to the Brand page for “MINK”, which is offered here for Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; biological preparations, cell therapies for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease;pharmaceutical, medical, scientific, and biopharmaceutical research and development;.

Its status is currently believed to be active. Its class is unavailable. “MINK” is believed to be currently owned by “AgenTus Therapeutics, Inc.”